Exploring patient and professional perspectives on implementing pharmacogenomic testing in the UK primary care setting and estimating the cost-effectiveness: a mixed-methods study protocol
Introduction Pharmacogenomic testing could potentially reduce the number of adverse drug reactions and improve treatment outcomes through tailoring treatment to an individual’s genetic makeup. Despite its benefits and the ambitions to integrate into routine care, the implementation of pharmacogenomi...
Saved in:
| Main Authors: | Asam Latif, Dyfrig A Hughes, Stephen Timmons, Anthony Avery, Sadaf Qureshi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/7/e104311.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Scoping review of enablers and challenges of implementing pharmacogenomics testing in the primary care settings
by: Chun-Wai Mai, et al.
Published: (2024-11-01) -
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
by: Marliese Alexander, et al.
Published: (2025-03-01) -
P309: Precision medicine in action: Implementation and utility of pharmacogenomic testing in a clinical setting
by: Hunter Slosser, et al.
Published: (2025-01-01) -
Pharmacogenomics
by: M S Shivashankara
Published: (2020-01-01) -
Implementing health economics for pharmacogenomics research translation in Africa
by: Mohamed Zahir Alimohamed, et al.
Published: (2025-06-01)